CUSIP N69605108COMPHVSQ4 2025
28 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | General Atlantic, L.P. | 8.03M | $222.87M |
| 2 | Fmr LLC | 6.40M | $177.58M |
| 3 | Foresite Capital Management IV, LLC | 4.78M | $132.61M |
| 4 | Venbio Partners LLC | 4.64M | $128.74M |
| 5 | Viking Global Investors LP | 3.65M | $101.38M |
| 6 | Eqt Fund Management S.A R.L. | 3.42M | $95.03M |
| 7 | Deerfield Management Company, L.P. | 3.13M | $86.75M |
| 8 | Bain Capital Life Sciences Investors, LLC | 2.80M | $77.76M |
| 4 | Feb 14, 2024 | Venrock Healthcare Capital Partners III, L.P. | 13G/A | 6.5% | 3.40M | SEC |
| 5 | Feb 14, 2024 | Viking Global Investors LP | 13G/A | 7.0% | 3.66M | SEC |
| 6 | Feb 13, 2024 | Foresite Capital Fund IV, L.P. | 13G/A | 7.8% | 4.04M | SEC |
| 7 | Feb 13, 2024 | General Atlantic, L.P. | 13G/A | 14.1% | 7.53M | SEC |
| 8 | Feb 9, 2024 | Fmr LLC | 13G/A | 10.0% | — | SEC |
| 9 | Feb 8, 2024 | Lsp V Cooperatieve U.A. | 13G/A | 6.8% | 3.56M | SEC |
| 10 | Jan 25, 2024 | Venbio Global Strategic Fund III, L.P. | 13D/A | 6.8% | 3.55M | SEC |
See the full Schedule 13D/13G history for Pharvaris N V.
Unlock full history| 9 |
| Wellington Management Group LLP |
| 1.91M |
| $52.89M |
| 10 | Commodore Capital LP | 1.89M | $52.43M |